Virbac stock heads into the open after a 1.57% decline
Published on 09/09/2026 at 08:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Virbac stock closed at EUR 314.50 on Euronext Paris on September 7, 2026, reflecting a 1.57% daily decline based on data cited from Boursorama. The move left the shares down 2.94% for the year to date as of that close, while the broader SBF 120 index posted a comparatively smaller loss for the session. Looking ahead, the next confirmed earnings date on September 17, 2026 is in focus as the company prepares to update investors.
September 7, 2026 in numbers
Virbac SA (ISIN FR0000031577) finished the September 7, 2026 session on Euronext Paris at EUR 314.50, after falling 1.57% from the prior close according to the market summary reported by Boursorama and relayed in an overview on Ad-hoc-news. The same report notes that this closing level corresponded to a 2.94% decline for the year to date as of September 7, 2026, showing that the shares have lagged modestly over the course of 2026. Within the French equity landscape, Virbac is part of the SBF 120 index, whose recent performance has been more resilient than the individual stock, highlighting a relative underperformance for Virbac shares over the year.
As detailed in the session recap carried by Ad-hoc-news, Virbac maintained its guidance earlier in 2026, and the market continues to compare the current share price with a target of EUR 440 set by Stifel on March 19, 2026. At the September 7, 2026 close of EUR 314.50, that target implies an upside gap of EUR 125.50, or 39.9%, underscoring that the stock trades well below at least one prominent analyst valuation reference. The article also emphasizes that investors are now orienting themselves toward the upcoming earnings date later in September, which is expected to provide updated financial figures and guidance commentary.
Outlook today and the next earnings date
The next confirmed reporting event for Virbac is the earnings release scheduled for September 17, 2026, as indicated in the forward-looking section of the same overview on Ad-hoc-news. With that date now less than two weeks away, today’s session is part of a short pre-earnings window in which market participants can adjust positions ahead of new information on revenue trends, margins and any potential updates to guidance. Broader European equities have recently been influenced by higher oil prices and cautious risk sentiment, as reflected in a pan-European market wrap from The Business Times, and these conditions may continue to shape trading appetite for Virbac ahead of its next results. In the absence of a company-specific release early on September 9, 2026, the main near-term milestone remains the September 17, 2026 earnings announcement, which is likely to be a key reference point for reassessing valuation and expectations.
